- Home
- FTHM vs KZR Comparison
FTHM vs KZR Comparison
Compare FTHM & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTHM
- KZR
- Stock Information
- Founded
- FTHM 2010
- KZR 2015
- Country
- FTHM United States
- KZR United States
- Employees
- FTHM N/A
- KZR N/A
- Industry
- FTHM Real Estate
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- FTHM Finance
- KZR Health Care
- Exchange
- FTHM Nasdaq
- KZR Nasdaq
- Market Cap
- FTHM 56.5M
- KZR 54.1M
- IPO Year
- FTHM 2020
- KZR 2018
- Fundamental
- Price
- FTHM $1.72
- KZR $6.29
- Analyst Decision
- FTHM Strong Buy
- KZR Hold
- Analyst Count
- FTHM 4
- KZR 2
- Target Price
- FTHM $4.25
- KZR $11.00
- AVG Volume (30 Days)
- FTHM 66.7K
- KZR 58.2K
- Earning Date
- FTHM 11-07-2024
- KZR 11-12-2024
- Dividend Yield
- FTHM N/A
- KZR N/A
- EPS Growth
- FTHM N/A
- KZR N/A
- EPS
- FTHM N/A
- KZR N/A
- Revenue
- FTHM $317,515,000.00
- KZR N/A
- Revenue This Year
- FTHM N/A
- KZR N/A
- Revenue Next Year
- FTHM $29.09
- KZR N/A
- P/E Ratio
- FTHM N/A
- KZR N/A
- Revenue Growth
- FTHM N/A
- KZR N/A
- 52 Week Low
- FTHM $1.32
- KZR $5.20
- 52 Week High
- FTHM $4.33
- KZR $11.40
- Technical
- Relative Strength Index (RSI)
- FTHM 33.40
- KZR 25.06
- Support Level
- FTHM $1.92
- KZR $6.80
- Resistance Level
- FTHM $2.06
- KZR $7.04
- Average True Range (ATR)
- FTHM 0.14
- KZR 0.26
- MACD
- FTHM -0.00
- KZR -0.07
- Stochastic Oscillator
- FTHM 5.51
- KZR 3.68
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.